Ampio Pharmaceuticals Inc. (AMPE) was among the biggest gainers on the Russell 2000 for September 11 as the stock popped 6.82% to $3.76, representing a gain of $0.24 per share. Some 1,781,186 shares traded hands on 6,174 trades, compared with an average daily volume of 1,428,307 shares out of a total float of 51,972,266. The stock opened at $3.52 and traded with an intraday range of $3.51 to $3.82.
After today's gains, Ampio Pharmaceuticals Inc. reached a market cap of $195,415,720. Ampio Pharmaceuticals Inc. has had a trading range between $10.86 and $3.44 over the last year, and it had a 50-day SMA of $6.19 and a 200-day SMA of $7.04.
Ampio Pharmaceuticals, Inc. is a biopharmaceutical company, engaged in developing innovative, proprietary pharmaceutical drugs and diagnostic products to identify, treat and prevent human diseases including metabolic disorders, cancer etc.
Ampio Pharmaceuticals Inc. is based out of Greenwood Village, CO and has some 16 employees. It's CEO is Michael Macaluso.
For a full analysis of Ampio Pharmaceuticals Inc., check out Equities.com's E.V.A. report.
The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.
Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.
For more news on the financial markets, go to Equities.com. Also, learn more about our Small-Cap Stars. Register to become a member and leverage our proprietary research tools such as the Small-Cap Stars, and robust do-it-yourself Equities Valuation Analysis (E.V.A.) research reports.
All data provided by QuoteMedia and was accurate as of 4:30PM ET.